eIF2Bα Inhibitors

EIF2Bα inhibitors belong to a class of chemical compounds designed to disrupt the function of the eukaryotic translation initiation factor 2B (EIF2Bα), a key regulatory protein complex involved in protein synthesis within eukaryotic cells. These inhibitors are typically small molecules or compounds that can interfere with the activity of EIF2Bα, leading to the modulation of cellular processes. EIF2Bα is a subunit of the EIF2B complex, which plays a pivotal role in the regulation of protein synthesis by mediating the exchange of guanine nucleotides on the translation initiation factor eIF2. This exchange of guanine nucleotides is a critical step in the initiation of translation of messenger RNAs (mRNAs), and EIF2Bα inhibitors target this specific aspect of translation initiation.

The mechanism of EIF2Bα inhibition typically involves either direct binding to EIF2Bα or interference with the guanine nucleotide exchange activity of the EIF2B complex. Some inhibitors, such as salubrinal and guanabenz, work by promoting the phosphorylation of eIF2α, a downstream target of EIF2B, leading to reduced EIF2B activity. Others, like integrated stress response inhibitors (ISRIB), act by reversing the inhibitory effects of phosphorylated eIF2α, restoring protein synthesis. Additionally, compounds like 2-aminopurine (2-AP) and hippuristanol target the guanine nucleotide exchange activity of EIF2B directly, disrupting its normal function. Overall, EIF2Bα inhibitors represent a class of compounds that hold promise for further research into their cellular mechanisms and applications in the modulation of protein synthesis within cells.